Our featured companies! Top picks


MediPharm Labs Corp.

TSE: LABS


Canadian symbol: LABS.TO
US symbol: MEDIF

Currency in CAD

Valuation Measures

Market Cap (intraday) 5107.48M
Enterprise Value 3110.57M
Trailing P/E N/A
Forward P/E 1-12.83
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)1.72
Price/Book (mrq)1.02
Enterprise Value/Revenue 31.77
Enterprise Value/EBITDA 6-2.67

Trading Information

Stock Price History

Beta (5Y Monthly) 0.87
52-Week Change 3-80.65%
S&P500 52-Week Change 313.47%
52 Week High 34.0700
52 Week Low 30.4850
50-Day Moving Average 30.5717
200-Day Moving Average 30.8441

Share Statistics

Avg Vol (3 month) 31.35M
Avg Vol (10 day) 34.18M
Shares Outstanding 5139.59M
Float 133.34M
% Held by Insiders 114.42%
% Held by Institutions 114.96%
Shares Short (Dec. 30, 2020) 44.61M
Short Ratio (Dec. 30, 2020) 45.14
Short % of Float (Dec. 30, 2020) 4N/A
Short % of Shares Outstanding (Dec. 30, 2020) 43.30%
Shares Short (prior month Nov. 29, 2020) 44.39M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Sep. 29, 2020

Profitability

Profit Margin -61.90%
Operating Margin (ttm)-72.56%

Management Effectiveness

Return on Assets (ttm)-16.98%
Return on Equity (ttm)-34.04%

Income Statement

Revenue (ttm)62.4M
Revenue Per Share (ttm)0.48
Quarterly Revenue Growth (yoy)-88.60%
Gross Profit (ttm)42.91M
EBITDA -41.38M
Net Income Avi to Common (ttm)-38.62M
Diluted EPS (ttm)-0.2970
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)36.46M
Total Cash Per Share (mrq)0.24
Total Debt (mrq)31.39M
Total Debt/Equity (mrq)30.10
Current Ratio (mrq)6.89
Book Value Per Share (mrq)0.75

Cash Flow Statement

Operating Cash Flow (ttm)-29.53M
Levered Free Cash Flow (ttm)-39.29M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
LABS.TO
MediPharm Labs
5 days ago
LABS.TO
MediPharm Labs
1 month ago
LABS.TO
MediPharm Labs
2 months ago
LABS.TO
MediPharm Labs
2 months ago
LABS.TO
MediPharm Labs
2 months ago
LABS.TO
MediPharm Labs
2 months ago
LABS.TO
MediPharm Labs
2 months ago
LABS.TO
MediPharm Labs
2 months ago
LABS.TO
MediPharm Labs
2 months ago
LABS.TO
MediPharm Labs
2 months ago
LABS.TO
MediPharm Labs
3 months ago
LABS.TO
MediPharm Labs
3 months ago
LABS.TO
MediPharm Labs
3 months ago
LABS.TO
MediPharm Labs
3 months ago
LABS.TO
MediPharm Labs
3 months ago
LABS.TO
MediPharm Labs
3 months ago
LABS.TO
MediPharm Labs
3 months ago
LABS.TO
MediPharm Labs
3 months ago
LABS.TO
MediPharm Labs
4 months ago
LABS.TO
MediPharm Labs
4 months ago
LABS.TO
MediPharm Labs
4 months ago
LABS.TO
MediPharm Labs
4 months ago
LABS.TO
MediPharm Labs
4 months ago
LABS.TO
MediPharm Labs
4 months ago
LABS.TO
MediPharm Labs
5 months ago
LABS.TO
MediPharm Labs
5 months ago
LABS.TO
MediPharm Labs
5 months ago
LABS.TO
MediPharm Labs
5 months ago
LABS.TO
MediPharm Labs
5 months ago
LABS.TO
MediPharm Labs
5 months ago
LABS.TO
MediPharm Labs
5 months ago
LABS.TO
MediPharm Labs
6 months ago
LABS.TO
MediPharm Labs
6 months ago
LABS.TO
MediPharm Labs
7 months ago
LABS.TO
MediPharm Labs
7 months ago
LABS.TO
MediPharm Labs
7 months ago
LABS.TO
MediPharm Labs
7 months ago
LABS.TO
MediPharm Labs
7 months ago
LABS.TO
MediPharm Labs
7 months ago
LABS.TO
MediPharm Labs
7 months ago
LABS.TO
MediPharm Labs
7 months ago
LABS.TO
MediPharm Labs
7 months ago
LABS.TO
MediPharm Labs
7 months ago
LABS.TO
MediPharm Labs
7 months ago
LABS.TO
MediPharm Labs
8 months ago
LABS.TO
MediPharm Labs
8 months ago
LABS.TO
MediPharm Labs
8 months ago
LABS.TO
MediPharm Labs
8 months ago
LABS.TO
MediPharm Labs
8 months ago
LABS.TO
MediPharm Labs
8 months ago
LABS.TO
MediPharm Labs
9 months ago
LABS.TO
MediPharm Labs
9 months ago
LABS.TO
MediPharm Labs
9 months ago
LABS.TO
MediPharm Labs
9 months ago
LABS.TO
MediPharm Labs
9 months ago
LABS.TO
MediPharm Labs
9 months ago
LABS.TO
MediPharm Labs
9 months ago
LABS.TO
MediPharm Labs
9 months ago
LABS.TO
MediPharm Labs
9 months ago
LABS.TO
MediPharm Labs
9 months ago
LABS.TO
MediPharm Labs
9 months ago
LABS.TO
MediPharm Labs
9 months ago
LABS.TO
MediPharm Labs
10 months ago
LABS.TO
MediPharm Labs
10 months ago
LABS.TO
MediPharm Labs
10 months ago
LABS.TO
MediPharm Labs
10 months ago
LABS.TO
MediPharm Labs
10 months ago
LABS.TO
MediPharm Labs
10 months ago
LABS.TO
MediPharm Labs
10 months ago
LABS.TO
MediPharm Labs
10 months ago
LABS.TO
MediPharm Labs
10 months ago
LABS.TO
MediPharm Labs
10 months ago
LABS.TO
MediPharm Labs
10 months ago
LABS.TO
MediPharm Labs
11 months ago
LABS.TO
MediPharm Labs
11 months ago
LABS.TO
MediPharm Labs
11 months ago
LABS.TO
MediPharm Labs
11 months ago
LABS.TO
MediPharm Labs
11 months ago
LABS.TO
MediPharm Labs
11 months ago
LABS.TO
MediPharm Labs
11 months ago
LABS.TO
MediPharm Labs
11 months ago
LABS.TO
MediPharm Labs
11 months ago
LABS.TO
MediPharm Labs
11 months ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago
LABS.TO
MediPharm Labs
1 year ago

Currency in CAD
Earnings EstimateCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2020)Next Year (2021)
No. of Analysts2245
Avg. Estimate-0.03-0.02-0.3-0.06
Low Estimate-0.04-0.03-0.34-0.2
High Estimate-0.02-0.02-0.270.05
Year Ago EPS-0.02-0.130.01-0.3
Revenue EstimateCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2020)Next Year (2021)
No. of Analysts3355
Avg. Estimate5.56M8.2M36.13M60.13M
Low Estimate4.9M6.4M34.9M40.5M
High Estimate6.47M10.99M38.65M93.74M
Year Ago Sales32.44M11.09M129.25M36.13M
Sales Growth (year/est)-82.90%-26.10%-72.00%66.40%
Earnings History2019-12-302020-03-302020-06-292020-09-29
EPS Est.0.01-0.01-0.04-0.03
EPS Actual-0.02-0.13-0.02-0.11
Difference-0.03-0.120.02-0.08
Surprise %-300.00%-1,200.00%50.00%-266.70%
EPS TrendCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2020)Next Year (2021)
Current Estimate-0.03-0.02-0.3-0.06
7 Days Ago-0.03-0.02-0.3-0.06
30 Days Ago-0.03-0.02-0.3-0.06
60 Days Ago-0.03-0.02-0.3-0.02
90 Days Ago-0.02-0.02-0.180.01
EPS RevisionsCurrent Qtr. (Dec 2020)Next Qtr. (Mar 2021)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesLABS.TOIndustrySector(s)S&P 500
Current Qtr.-50.00%N/AN/AN/A
Next Qtr.84.60%N/AN/AN/A
Current Year-3,100.00%N/AN/AN/A
Next Year80.00%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
14.42%% of Shares Held by All Insider
14.96%% of Shares Held by Institutions
17.48%% of Float Held by Institutions
15Number of Institutions Holding Shares

Top Institutional Holders

HolderSharesDate Reported% OutValue
AdvisorShares Investments, LLC551,454Sep. 29, 20200.38%485,279

Top Mutual Fund Holders

HolderSharesDate Reported% OutValue
ETF Managers Tr-EFTMG Alternative Harvest ETF7,497,753Sep. 29, 20205.20%6,598,022
Global X Fds-The Global X Cannabis ETF2,003,960Dec. 30, 20201.39%1,062,098
Spinnaker ETF Tr-Cannabis ETF1,131,075Aug. 30, 20200.78%1,051,899
AdvisorShares Trust-AdvisorShares Pure Cannabis ETF551,454Sep. 29, 20200.38%485,279
Cambria ETF Tr-Cambria Cannabis ETF400,452Dec. 30, 20200.28%212,239
Amplify Seymour Cannabis ETF279,090Dec. 30, 20200.19%147,917
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by MediPharm Labs Corp.


MediPharm Labs Appoints Warren Everitt, CEO Australia Pacific, to Board of Directors

MediPharm Labs Appoints Warren Everitt, CEO Australia Pacific, to Board of Directors

TORONTO, Jan. 15, 2021 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced the appointment of Warren Everitt to its Board of Directors (the “Board”),... Read More...
MediPharm Labs Announces Leadership Changes

MediPharm Labs Announces Leadership Changes

BARRIE, Ontario, Dec. 10, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a global leader in specialized, research-driven cannabis extraction, distillation and derivative products, today announced a senior leadership transition.To prepare the Company for its next phase of growth and ... Read More...
MediPharm Labs First to Launch THC-Free, 99% Pure CBD Isolate Consumer Sized Crystal in Canada

MediPharm Labs First to Launch THC-Free, 99% Pure CBD Isolate Consumer Sized Crystal in Canada

BARRIE, Ontario, Oct. 29, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced the launch of LABS Cannabis CBD Isolate, the first in its LABS Ca... Read More...
MediPharm Labs Sets Date to Release Third Quarter 2020 Financial Results

MediPharm Labs Sets Date to Release Third Quarter 2020 Financial Results

TORONTO, Oct. 28, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce it will release third quarter financial results for the three and n... Read More...
MediPharm Labs Enters New GMP Manufacturing Deal with Sunco Green Pharmaceutical Pty Ltd. in Australia

MediPharm Labs Enters New GMP Manufacturing Deal with Sunco Green Pharmaceutical Pty Ltd. in Australia

MediPharm and Sunco Green to bring GMP certified cannabis products to a burgeoning Australian cannabis market beginning in Q4 2020In September 2020, over 6,000 patients were approved for medical cannabis treatment in Australia an 72% increase from approvals granted nearly 1 year agoApproximately 67,000 applications for medicinal cannabis ... Read More...
MediPharm Labs Launches LABS CANNABIS, A New and Innovative Family of Health and Wellness Products

MediPharm Labs Launches LABS CANNABIS, A New and Innovative Family of Health and Wellness Products

BARRIE, Ontario, Oct. 20, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce the launch of its new “LABS Cannabis” family of health and... Read More...
MediPharm Labs Initiates Clinical Trial for Use of Cannabis to Treat Chronic Kidney Disease Patients and Improve Quality of Life

MediPharm Labs Initiates Clinical Trial for Use of Cannabis to Treat Chronic Kidney Disease Patients and Improve Quality of Life

Clinical trial will evaluate the effectiveness of MediPharm Labs proprietary GMP cannabis-derived formulations and medical products and expand MediPharm Labs owned IPIn the United States, 37 million or more than 1 in 7 adults, are estimated to have chronic kidney disease (CKD) and Worldwide, approximately 1 in 10 people suffer from kidney... Read More...
European Pharmaceutical Company STADA Enters Exclusive Medical Cannabis Partnership with MediPharm Labs

European Pharmaceutical Company STADA Enters Exclusive Medical Cannabis Partnership with MediPharm Labs

A milestone for the global cannabis industry as STADA, in partnership with MediPharm, forges the way as a large pharmaceutical company commercializing medical cannabis productsPartnership validates MediPharm Labs’ GMP pharmaceutical-quality cannabis production and, combined with STADA’s 125-year heritage and experienced marketing and sale... Read More...
MediPharm Labs Secures 100% Ownership of its Australia Subsidiary, Poised for New Wave of Global Medicinal Cannabis Growth

MediPharm Labs Secures 100% Ownership of its Australia Subsidiary, Poised for New Wave of Global Medicinal Cannabis Growth

TORONTO, Sept. 28, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced it has entered into a share sale and purchase agreement (the “Buyout Agre... Read More...
MediPharm Labs Expands Denmark Revenue Opportunity, Enters New Supply Agreement with DanCann Pharma

MediPharm Labs Expands Denmark Revenue Opportunity, Enters New Supply Agreement with DanCann Pharma

TORONTO, Sept. 25, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced it has entered into a new white-label supply agreement with DanCann Pharm... Read More...
MediPharm Labs Enters Brazil – Latin America's Largest Medical Cannabis Market in Partnership with XLR8 Brazil

MediPharm Labs Enters Brazil – Latin America’s Largest Medical Cannabis Market in Partnership with XLR8 Brazil

BARRIE, Ontario, Sept. 22, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced its wholly owned subsidiary MediPharm Labs Inc. will supply prem... Read More...
MediPharm Labs Enters Growing Latin American Medical Cannabis Market; Enters Supply Agreement With Cann Farm Peru

MediPharm Labs Enters Growing Latin American Medical Cannabis Market; Enters Supply Agreement With Cann Farm Peru

BARRIE, Ontario, Sept. 03, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced its wholly owned subsidiary MediPharm Labs Inc. will supply prem... Read More...
MediPharm Labs and Georgian College Complete First Research and Innovation Collaboration Driving Data and Analytics Insights

MediPharm Labs and Georgian College Complete First Research and Innovation Collaboration Driving Data and Analytics Insights

BARRIE, Ontario, Sept. 02, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that its wholly-owned subsidiary, MediPharm Labs Inc., ha... Read More...
MediPharm Labs Enters Denmark Medical Cannabis Market, Secures New White-Label Supply Customers

MediPharm Labs Enters Denmark Medical Cannabis Market, Secures New White-Label Supply Customers

TORONTO, Sept. 01, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced it will supply cannabis concentrate products in Denmark to two new medica... Read More...
MediPharm Labs Australia Expands Revenue Opportunity On Expanded GMP Licence

MediPharm Labs Australia Expands Revenue Opportunity On Expanded GMP Licence

BARRIE, Ontario, Aug. 19, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced that its Australian operation – MediPharm Labs Australia Pty. Ltd... Read More...
MediPharm Labs Reports Second Quarter 2020 Results, Strong Progress With International Expansion

MediPharm Labs Reports Second Quarter 2020 Results, Strong Progress With International Expansion

BARRIE, Ontario, Aug. 13, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced its financial results for the three and six months ended June 30,... Read More...
MediPharm Labs Announces Voting Results From the 2020 Annual and Special Meeting of Shareholders

MediPharm Labs Announces Voting Results From the 2020 Annual and Special Meeting of Shareholders

BARRIE, Ontario, Aug. 05, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced the results of matters voted on at its annual and special meeting... Read More...
MediPharm Labs Appoints Former President of Janssen Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to Board of Directors

MediPharm Labs Appoints Former President of Janssen Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to Board of Directors

TORONTO, Aug. 04, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce the appointment of Chris Halyk – former President of Janssen Inc. (... Read More...
MediPharm Labs and Hybrid Pharm Partner to Offer New Same Day Registration and Delivery Service of Medical Cannabis

MediPharm Labs and Hybrid Pharm Partner to Offer New Same Day Registration and Delivery Service of Medical Cannabis

BARRIE, Ontario, July 29, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced it will supply premium, pharmaceutical-quality cannabis products ... Read More...
MediPharm Labs to Participate in the “Cannabis Chronicles”, Fireside Chat with Alliance Global Partners Senior Analyst Aaron Grey

MediPharm Labs to Participate in the “Cannabis Chronicles”, Fireside Chat with Alliance Global Partners Senior Analyst Aaron Grey

BARRIE, Ontario, July 29, 2020 -- MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that MediPharm Labs’ management will participate in the “... Read More...
MediPharm Labs Achieves First Sales Milestone in Australia, Global Sales for GMP Products Continue to Ramp Up in Q3 2020

MediPharm Labs Achieves First Sales Milestone in Australia, Global Sales for GMP Products Continue to Ramp Up in Q3 2020

In June, shipped approximately $500,000 AUD in GMP Pharma-Quality product for distribution to Australian customersOver 12 white-label supply agreements completed YTD 2020, offering multiple formulationsRobust sales pipeline in Europe and Asia Pacific demonstrates demand for MediPharm Labs’ GMP certified products       TORONTO, July 23, 20... Read More...
Pat McCutcheon, CEO of MediPharm Labs to Present at the Avicanna Hosted Virtual Symposium Titled "Medical Cannabis 2.0" in Partnership with Medical Cannabis by Shoppers™

Pat McCutcheon, CEO of MediPharm Labs to Present at the Avicanna Hosted Virtual Symposium Titled “Medical Cannabis 2.0” in Partnership with Medical Cannabis by Shoppers™

This year's annual symposium coincides with the expected launch of Avicanna Inc's (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) RHO Phyto™ advanced medical cannabis products, manufactured by MediPharm Labs.In the wake of COVID-19, a virtual format will be used that allows for a broader reach to global patients and the medical community. The sympo... Read More...
MediPharm Labs Selected by University Health Network and Medical Cannabis by Shoppers Inc. for First Real-World Evidence, Patient-Centred Clinical Trial Using Blockchain Technology

MediPharm Labs Selected by University Health Network and Medical Cannabis by Shoppers Inc. for First Real-World Evidence, Patient-Centred Clinical Trial Using Blockchain Technology

TORONTO, July 16, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced its participation in a ground-breaking collaboration between University He... Read More...
MediPharm Labs Appoints BMO Capital Markets Executive to Board of Directors

MediPharm Labs Appoints BMO Capital Markets Executive to Board of Directors

TORONTO, July 14, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is delighted to announce the appointment of Chris Taves – Chief Operating Officer (“COO”)... Read More...
MediPharm Labs to Participate at CBD BioPharma Virtual Investor Conference

MediPharm Labs to Participate at CBD BioPharma Virtual Investor Conference

BARRIE, Ontario, July 09, 2020 -- MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that MediPharm Labs’ management will participate in the C... Read More...
MediPharm Labs Sets Date to Release Second Quarter 2020 Financial Results

MediPharm Labs Sets Date to Release Second Quarter 2020 Financial Results

BARRIE, Ontario, July 02, 2020 -- MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce it will release its second quarter financial results for ... Read More...
MediPharm Labs Expands Innovative CBD Product Portfolio By Introducing CBD25:5 Release Formula

MediPharm Labs Expands Innovative CBD Product Portfolio By Introducing CBD25:5 Release Formula

TORONTO, June 25, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced a further expansion of its innovative, pharma-quality family of branded pr... Read More...
MediPharm Labs Appoints Former Nestlé Canada President and CEO, Shelley Martin, to Board of Directors

MediPharm Labs Appoints Former Nestlé Canada President and CEO, Shelley Martin, to Board of Directors

TORONTO, June 22, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is delighted to announce the appointment of Shelley Martin – former President and CEO of N... Read More...
Tetra Bio-Pharma Discusses the Potential of Their ARDS-003 Drug in the Fight Against COVID-19 with the Stock Day Podcast

Tetra Bio-Pharma Discusses the Potential of Their ARDS-003 Drug in the Fight Against COVID-19 with the Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - June 22, 2020) - The Stock Day Podcast welcomed Tetra Bio-Pharma (TSXV: TBP) (OTCQB: TBPMF) ("the Company"), a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed and approved, clinical program aimed at bringing novel prescription ... Read More...
MediPharm Labs Australia Enters Into New Supply Agreement With VIVO Cannabis and Prepares to Commence Sales

MediPharm Labs Australia Enters Into New Supply Agreement With VIVO Cannabis and Prepares to Commence Sales

Large shipment of 35,000 units of formulated finished products and bulk extract completed to MPL Australia to support commencement of sales revenueTORONTO, June 19, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality ca... Read More...
MediPharm Labs Reports First Quarter 2020 Results, Clears Path for International Growth

MediPharm Labs Reports First Quarter 2020 Results, Clears Path for International Growth

BARRIE, Ontario, June 18, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation and derivative products, today announced its financial results for the three months ended March 31, 2020. The Company also provid... Read More...
MediPharm Labs Sets Date to Release First Quarter 2020 Financial Results and Provides Corporate Update

MediPharm Labs Sets Date to Release First Quarter 2020 Financial Results and Provides Corporate Update

BARRIE, Ontario, June 11, 2020 -- MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce it will release and file its first quarter 2020 financial... Read More...
MediPharm Labs Accelerates Growth of Pharma-Quality Product Portfolio With Launch of its New CBD50 Plus Formula

MediPharm Labs Accelerates Growth of Pharma-Quality Product Portfolio With Launch of its New CBD50 Plus Formula

TORONTO, June 04, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced a significant advancement for Canadian consumers with the introduction of ... Read More...
MediPharm Labs and Argentia Gold to Bring Premium Cannabis-Infused Products to Atlantic Canada

MediPharm Labs and Argentia Gold to Bring Premium Cannabis-Infused Products to Atlantic Canada

BARRIE, Ontario, May 27, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products and Argentina Gold Corporation (“Argentia Gold”), a Canadian vertically integrated ... Read More...
MediPharm Labs and Ace Valley Deliver Innovative Vapes - Now Available in Several Markets Across Canada

MediPharm Labs and Ace Valley Deliver Innovative Vapes – Now Available in Several Markets Across Canada

TORONTO, May 25, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”), a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that its highly anticipated and innovative suite of “Ace Valley Va... Read More...
MediPharm Labs Australia Signs First European White-Label Cannabis Supply Agreement With UK-Based Cannaray's Therismos

MediPharm Labs Australia Signs First European White-Label Cannabis Supply Agreement With UK-Based Cannaray’s Therismos

BARRIE, Ontario, May 15, 2020 -- MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that its subsidiary, MediPharm Labs Australia Pty. Ltd. (“... Read More...
MediPharm Labs Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with Biopharmaceutical Leader Avicanna Inc.

MediPharm Labs Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with Biopharmaceutical Leader Avicanna Inc.

BARRIE, Ontario, May 14, 2020 -- MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that it has signed a multi-faceted strategic manufacturing... Read More...
MediPharm Labs to File First Quarter Financial Statements and MD&A in June 2020, Provides Q1 Update

MediPharm Labs to File First Quarter Financial Statements and MD&A in June 2020, Provides Q1 Update

BARRIE, Ontario, May 14, 2020 -- MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products today announced that it will file its first quarter 2020 financial statements and ... Read More...
MediPharm Labs Australia Granted GMP Certificate and Licence to Manufacture Therapeutic Goods; On Track to Ramp Up and Fulfill New Supply Agreements

MediPharm Labs Australia Granted GMP Certificate and Licence to Manufacture Therapeutic Goods; On Track to Ramp Up and Fulfill New Supply Agreements

BARRIE, Ontario, May 07, 2020 -- MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is delighted to announce that its subsidiary, MediPharm Labs Australia Pty. Ltd. ... Read More...
MediPharm Labs Australia Signs its Second GMP White-Label Deal to Supply New Zealand's Medical Cannabis Market

MediPharm Labs Australia Signs its Second GMP White-Label Deal to Supply New Zealand’s Medical Cannabis Market

BARRIE, Ontario, May 04, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that its subsidiary, MediPharm Labs Australia Pty Ltd (“Med... Read More...
MediPharm Labs Australia Signs First International White-Label Supply Deal with New Zealand based Helius Therapeutics

MediPharm Labs Australia Signs First International White-Label Supply Deal with New Zealand based Helius Therapeutics

BARRIE, Ontario, April 24, 2020 -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that its subsidiary, MediPharm Labs Australia Pty Ltd (“M... Read More...
CHAMPIGNON TO ACQUIRE ALTMED CAPITAL CORP., CONTRIBUTING HEALTH CANADA'S ONLY APPROVED PSYCHEDELIC MEDICINE CLINIC, SOPs FOR CLINICAL EXPANSION, EXISTING IP & MULTIPLE TRIALS

CHAMPIGNON TO ACQUIRE ALTMED CAPITAL CORP., CONTRIBUTING HEALTH CANADA’S ONLY APPROVED PSYCHEDELIC MEDICINE CLINIC, SOPs FOR CLINICAL EXPANSION, EXISTING IP & MULTIPLE TRIALS

VANCOUVER, British Columbia, April 09, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, continues to accel... Read More...
Coming Soon.
SymbolExchangePriceChangeAs of
LABS.TO
The Toronto Stock Exchange
The Toronto Stock Exchange0.77CAD0.00%
MLZ.F
Frankfurt Stock Exchange
Frankfurt Stock Exchange0.52EUR-4.63%
MEDIF.PK
US 'Other OTC' and Grey Market
US 'Other OTC' and Grey Market0.60USD-8.45%
MLZ.BE
Berlin Stock Exchange
Berlin Stock Exchange0.53EUR-2.78%
LABS.GO
Canadian Securities Exchange/PURE - CSE Listed & Other Canadian Listed Securities
Canadian Securities Exchange/PURE - CSE Listed & Other Canadian Listed Securities0.78CAD-6.02%
MLZ.MU
Munich Stock Exchange
Munich Stock Exchange0.54EUR-4.42%
MLZ.SG
Stuttgart Stock Exchange
Stuttgart Stock Exchange0.56EUR+8.82%
MLZ.D
Dusseldorf Stock Exchange
Dusseldorf Stock Exchange0.54EUR+12.50%

Delayed data (1h)
NameAgePositionAppointed
Patrick McCutcheon
Chairman of the Board, Chief Executive Officer and Director
--Chairman of the Board, Chief Executive Officer and Director2018
Keith Strachan
President, Director
--President, Director2019
Robert Hyok-Chin Kwon
Chief Financial Officer
--Chief Financial Officer2019
Sybil Taylor
Chief Marketing Officer
--Chief Marketing Officer--
Warren Everitt
Managing Director - MediPharm Labs Australia
--Managing Director - MediPharm Labs Australia--
Braden William Fenske
Chief Strategy Officer
--Chief Strategy Officer2019
Christopher J. Hobbs
Director
--Director2019
Shelley Martin
Independent Director
--Independent Director2020
Miriam McDonald
Director
--Director2018
Marufur Syed Raza
Director
--Director2018
Paul Tam
Director
--Director2019
Chris Taves
Director
--Director2020
Chris Halyk
Independent Director
--Independent Director2020


Share this page